Formoterol vs short‐acting beta2‐agonist
Asthma‐related serious adverse event · people with asthma
Formoterol showed no clear difference in patients with a serious adverse event (asthma related) compared with short‐acting beta2‐agonist (low certainty).
1 finding from 1 review
- Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma 2010 · Cochrane Headline outcomes onlyOR 0.91 [0.72, 1.15]6 studies · 21986 participantsLow